Skip to main content
SpringerLink
Log in

NICE recommends novel HF drug

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. New York Heart Association (NYHA) class II to IV symptoms

  2. LVEF = left ventricular ejection fraction

Reference

  • NICE. NICE gives green light to new drug set to benefit 100,000 people with common heart condition. Media Release : 26 Apr 2016. Available from: URL: http://www.nice.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

NICE recommends novel HF drug. PharmacoEcon Outcomes News 752, 36 (2016). https://doi.org/10.1007/s40274-016-3030-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3030-4

Search

Navigation